2015 Q1 Form 10-K Financial Statement

#000114519715000020 Filed on February 26, 2015

View on sec.gov

Income Statement

Concept 2015 Q1 2014 Q4 2014
Revenue $48.15M $58.36M $231.3M
YoY Change -13.02% -14.84% 24.94%
Cost Of Revenue $18.96M -$5.300M $104.2M
YoY Change -47.86% -114.93% 9.26%
Gross Profit $29.19M $33.12M $127.1M
YoY Change 2.67% 0.3% 41.61%
Gross Profit Margin 60.63% 56.74% 54.96%
Selling, General & Admin $28.25M $12.10M $108.1M
YoY Change 1.21% -54.17% 14.17%
% of Gross Profit 96.78% 36.54% 85.03%
Research & Development $8.207M $7.300M $27.90M
YoY Change 21.07% 14.06% 28.19%
% of Gross Profit 28.11% 22.04% 21.95%
Depreciation & Amortization $3.433M $3.050M $12.22M
YoY Change 11.82% 3.39% 3.53%
% of Gross Profit 11.76% 9.21% 9.61%
Operating Expenses $36.46M $19.30M $136.0M
YoY Change 5.09% -41.16% 16.79%
Operating Profit -$7.266M $13.82M -$8.874M
YoY Change 285.26% 6238.53% -66.73%
Interest Expense -$3.200M -$3.000M -$15.80M
YoY Change -1166.67% 3.45% 2.6%
% of Operating Profit -21.71%
Other Income/Expense, Net -$3.152M -$100.0K -$39.01M
YoY Change -24.83% 147.14%
Pretax Income -$10.42M -$1.900M -$47.88M
YoY Change 71.38% -29.63% 12.77%
Income Tax $24.00K -$100.0K $60.00K
% Of Pretax Income
Net Earnings -$11.83M -$5.400M -$51.50M
YoY Change 92.61% 116.0% 14.51%
Net Earnings / Revenue -24.58% -9.25% -22.26%
Basic Earnings Per Share
Diluted Earnings Per Share -$208.8K -$96.09K -$926.3K
COMMON SHARES
Basic Shares Outstanding 56.45M shares 56.08M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q1 2014 Q4 2014
SHORT-TERM ASSETS
Cash & Short-Term Investments $145.6M $151.2M $151.2M
YoY Change 0.0% 1.0% 1.0%
Cash & Equivalents $145.6M $151.2M $151.2M
Short-Term Investments
Other Short-Term Assets $3.700M $4.000M $4.000M
YoY Change -47.89% -32.2% -32.2%
Inventory $20.07M $11.45M $13.10M
Prepaid Expenses
Receivables $36.09M $35.24M $39.90M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $205.4M $208.2M $208.2M
YoY Change 2.79% 5.04% 5.05%
LONG-TERM ASSETS
Property, Plant & Equipment $44.61M $36.94M $37.10M
YoY Change 37.03% 14.17% 14.51%
Goodwill $37.54M $37.40M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.986M $294.0K $300.0K
YoY Change 201.82% -83.89% -83.33%
Total Long-Term Assets $100.3M $88.99M $89.00M
YoY Change 13.1% -0.86% -0.89%
TOTAL ASSETS
Total Short-Term Assets $205.4M $208.2M $208.2M
Total Long-Term Assets $100.3M $88.99M $89.00M
Total Assets $305.7M $297.2M $297.2M
YoY Change 5.96% 3.2% 3.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $14.25M $12.58M $14.70M
YoY Change -32.11% -35.02% -24.23%
Accrued Expenses $25.27M $18.85M $24.70M
YoY Change 34.61% -3.22% 26.67%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $6.000M $3.400M $3.400M
YoY Change 114.29% 30.77%
Total Short-Term Liabilities $47.38M $44.30M $44.30M
YoY Change 9.88% 4.54% 4.48%
LONG-TERM LIABILITIES
Long-Term Debt $170.6M $164.0M $166.3M
YoY Change 46.71% 44.32% 39.75%
Other Long-Term Liabilities $3.038M $2.774M $2.800M
YoY Change 53.13% 42.77% 47.37%
Total Long-Term Liabilities $173.6M $166.8M $169.1M
YoY Change 46.82% 44.29% 39.87%
TOTAL LIABILITIES
Total Short-Term Liabilities $47.38M $44.30M $44.30M
Total Long-Term Liabilities $173.6M $166.8M $169.1M
Total Liabilities $225.0M $213.4M $213.4M
YoY Change 35.5% 30.6% 30.6%
SHAREHOLDERS EQUITY
Retained Earnings -$589.9M -$578.0M
YoY Change 10.74% 9.78%
Common Stock $57.00K $56.00K
YoY Change 3.64% 1.82%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $80.74M $83.83M $83.80M
YoY Change
Total Liabilities & Shareholders Equity $305.7M $297.2M $297.2M
YoY Change 5.96% 3.2% 3.19%

Cashflow Statement

Concept 2015 Q1 2014 Q4 2014
OPERATING ACTIVITIES
Net Income -$11.83M -$5.400M -$51.50M
YoY Change 92.61% 116.0% 14.51%
Depreciation, Depletion And Amortization $3.433M $3.050M $12.22M
YoY Change 11.82% 3.39% 3.53%
Cash From Operating Activities -$3.488M $4.610M $8.920M
YoY Change 242.97% -230.97% 166.43%
INVESTING ACTIVITIES
Capital Expenditures $4.346M -$2.640M $11.49M
YoY Change 101.48% -5.38% 57.19%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$4.346M -$2.640M -$11.49M
YoY Change 101.48% -5.38% 57.19%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $4.876M $11.59M
YoY Change 36.93% -88.71%
Debt Paid & Issued, Net $189.5M
YoY Change 9376.05%
Cash From Financing Activities $2.249M 2.840M $4.032M
YoY Change -339.51% 33.33% -95.82%
NET CHANGE
Cash From Operating Activities -$3.488M 4.610M $8.920M
Cash From Investing Activities -$4.346M -2.640M -$11.49M
Cash From Financing Activities $2.249M 2.840M $4.032M
Net Change In Cash -$5.585M 4.810M $1.466M
YoY Change 35.79% -215.07% -98.41%
FREE CASH FLOW
Cash From Operating Activities -$3.488M $4.610M $8.920M
Capital Expenditures $4.346M -$2.640M $11.49M
Free Cash Flow -$7.834M $7.250M -$2.566M
YoY Change 146.82% -1093.15% -35.19%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014 dei Amendment Flag
AmendmentFlag
false
CY2014 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2014 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2014 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014 dei Document Period End Date
DocumentPeriodEndDate
2014-12-31
CY2014 dei Document Type
DocumentType
10-K
CY2014 dei Entity Central Index Key
EntityCentralIndexKey
0001145197
CY2015Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
56447961 shares
CY2014 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2014 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2014Q2 dei Entity Public Float
EntityPublicFloat
2200000000 USD
CY2014 dei Entity Registrant Name
EntityRegistrantName
INSULET CORP
CY2014 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2014 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2014 dei Trading Symbol
TradingSymbol
PODD
CY2013Q4 podd Accrued Supplier Charges
AccruedSupplierCharges
1850000 USD
CY2014Q4 podd Accrued Supplier Charges
AccruedSupplierCharges
1852000 USD
CY2013Q4 podd Accrued Training Current
AccruedTrainingCurrent
717000 USD
CY2014Q4 podd Accrued Training Current
AccruedTrainingCurrent
770000 USD
CY2014 podd Capital Leasesof Lessee Contingent Rentals Effective Interest Rate
CapitalLeasesofLesseeContingentRentalsEffectiveInterestRate
0.17
CY2013Q4 podd Debt Instrument Modified Debt Unamortized Discount
DebtInstrumentModifiedDebtUnamortizedDiscount
30100000 USD
CY2012 podd Debt Instrument Stated Coupon Rate Interest Expense
DebtInstrumentStatedCouponRateInterestExpense
6197000 USD
CY2013 podd Debt Instrument Stated Coupon Rate Interest Expense
DebtInstrumentStatedCouponRateInterestExpense
5704000 USD
CY2014 podd Debt Instrument Stated Coupon Rate Interest Expense
DebtInstrumentStatedCouponRateInterestExpense
4657000 USD
CY2012 podd Deferred Compensation Arrangement With Individual Required Service Period
DeferredCompensationArrangementWithIndividualRequiredServicePeriod
P4Y
CY2013 podd Deferred Compensation Arrangement With Individual Required Service Period
DeferredCompensationArrangementWithIndividualRequiredServicePeriod
P4Y
CY2014 podd Deferred Compensation Arrangement With Individual Required Service Period
DeferredCompensationArrangementWithIndividualRequiredServicePeriod
P4Y
CY2013Q4 podd Deferred Tax Assets Depreciation
DeferredTaxAssetsDepreciation
1675000 USD
CY2014Q4 podd Deferred Tax Assets Depreciation
DeferredTaxAssetsDepreciation
897000 USD
CY2013Q4 podd Deferred Tax Assets Start Up Costs
DeferredTaxAssetsStartUpCosts
1672000 USD
CY2014Q4 podd Deferred Tax Assets Start Up Costs
DeferredTaxAssetsStartUpCosts
1416000 USD
CY2013Q4 podd Deferred Tax Liabilities Gross
DeferredTaxLiabilitiesGross
18996000 USD
CY2014Q4 podd Deferred Tax Liabilities Gross
DeferredTaxLiabilitiesGross
18404000 USD
CY2012 podd Defined Contribution Plan Employer Discretionary Match Percentage
DefinedContributionPlanEmployerDiscretionaryMatchPercentage
0.50
CY2013 podd Defined Contribution Plan Employer Discretionary Match Percentage
DefinedContributionPlanEmployerDiscretionaryMatchPercentage
0.50
CY2014 podd Defined Contribution Plan Employer Discretionary Match Percentage
DefinedContributionPlanEmployerDiscretionaryMatchPercentage
0.50
CY2014 podd Defined Contribution Plan Service Period
DefinedContributionPlanServicePeriod
P30D
CY2014 podd Expected Cash Interest Payments Next Twelve Months
ExpectedCashInterestPaymentsNextTwelveMonths
4000000 USD
CY2014 podd Expected Cash Interest Payments Year2
ExpectedCashInterestPaymentsYear2
4000000 USD
CY2014 podd Expected Cash Interest Payments Year3
ExpectedCashInterestPaymentsYear3
4000000 USD
CY2014 podd Expected Cash Interest Payments Year4
ExpectedCashInterestPaymentsYear4
4000000 USD
CY2014 podd Expected Cash Interest Payments Year5
ExpectedCashInterestPaymentsYear5
1800000 USD
CY2014 podd Expected Future Principal Payments
ExpectedFuturePrincipalPayments
201300000 USD
CY2013Q4 podd Fair Value Assumption Bond Call Strike Price
FairValueAssumptionBondCallStrikePrice
100
CY2013 podd Fair Value Assumption Conversion Price
FairValueAssumptionConversionPrice
26.20
CY2013 podd Fair Value Assumption Coupon Rate
FairValueAssumptionCouponRate
0.0375
CY2013 podd Fair Value Assumptions Bond Yield
FairValueAssumptionsBondYield
0.0861
CY2014 podd Fullydepreciatedassetswrittenoff
Fullydepreciatedassetswrittenoff
19800000 USD
CY2012 podd Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities
IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities
2999000 USD
CY2013 podd Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities
IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities
10425000 USD
CY2014 podd Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities
IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities
525000 USD
CY2014 podd Management Transition Costs
ManagementTransitionCosts
10400000 USD
CY2013Q4 podd Number Of Customers With Greater Than Ten Percent Accounts Receivable Balance
NumberOfCustomersWithGreaterThanTenPercentAccountsReceivableBalance
2 Customer
CY2014Q4 podd Number Of Customers With Greater Than Ten Percent Accounts Receivable Balance
NumberOfCustomersWithGreaterThanTenPercentAccountsReceivableBalance
2 Customer
CY2014Q4 podd Number Of Financial Institution
NumberOfFinancialInstitution
2 Location
CY2014Q4 podd Number Of Inches Of Tubing In Conventional Insulin Pump
NumberOfInchesOfTubingInConventionalInsulinPump
42 in
CY2013Q4 podd Number Of Single Source Suppliers
NumberOfSingleSourceSuppliers
1 Customer
CY2014Q4 podd Number Of Single Source Suppliers
NumberOfSingleSourceSuppliers
1 Customer
CY2013 podd Percentage Of Accounts Payable Accrued Expensesand Other Current Liabilities
PercentageOfAccountsPayableAccruedExpensesandOtherCurrentLiabilities
0.36
CY2014 podd Percentage Of Accounts Payable Accrued Expensesand Other Current Liabilities
PercentageOfAccountsPayableAccruedExpensesandOtherCurrentLiabilities
0.24
CY2014 podd Product Warranty Term
ProductWarrantyTerm
P4Y
CY2014 podd Repayment Periodfor Capital Lease Obligations
RepaymentPeriodforCapitalLeaseObligations
P36M
CY2014 podd Return Period
ReturnPeriod
P45D
CY2014 podd Share Based Compensation Arrangementby Share Based Payment Award Additional Expense
ShareBasedCompensationArrangementbyShareBasedPaymentAwardAdditionalExpense
900000 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
19359000 USD
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
14659000 USD
CY2013Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
40200000 USD
CY2014Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
45719000 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
33067000 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
39882000 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19478000 USD
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
24703000 USD
CY2013Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2437000 USD
CY2014Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4373000 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
34462000 USD
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22916000 USD
CY2014 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P7Y
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
651067000 USD
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
661798000 USD
CY2012 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
0 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
0 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
35638000 USD
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9862000 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12616000 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
22432000 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
5000000 USD
CY2012 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9900000 USD
CY2013 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12700000 USD
CY2014 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
22500000 USD
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
7133000 USD
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5837000 USD
CY2012 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
9619000 USD
CY2013 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
10492000 USD
CY2014 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
8007000 USD
CY2012 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
593000 USD
CY2013 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
590000 USD
CY2014 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
895000 USD
CY2012 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
10212000 USD
CY2013 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
9731000 USD
CY2014 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
10253000 USD
CY2012 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6000000 USD
CY2013 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4900000 USD
CY2014 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4000000 USD
CY2012 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9580353 shares
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8328148 shares
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6921538 shares
CY2012 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2013 us-gaap Asset Impairment Charges
AssetImpairmentCharges
2511000 USD
CY2014 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2013Q4 us-gaap Assets
Assets
287955000 USD
CY2014Q4 us-gaap Assets
Assets
302156000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
198198000 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
208196000 USD
CY2013Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
2637000 USD
CY2014Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
3380000 USD
CY2012 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
0 USD
CY2013 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
9021000 USD
CY2014 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
1474000 USD
CY2013Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
5390000 USD
CY2014Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
2263000 USD
CY2014Q4 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
6476000 USD
CY2014Q4 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
4068000 USD
CY2014Q4 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
2408000 USD
CY2014Q4 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
833000 USD
CY2014Q4 us-gaap Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments
CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments
5643000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
93955000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
57293000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
149727000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
151193000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
128308000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
123141000 USD
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-36662000 USD
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
92434000 USD
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1466000 USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
54870424 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
56299022 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
54870424 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
56299022 shares
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
55000 USD
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
56000 USD
CY2012 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
119033000 USD
CY2013 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
134683000 USD
CY2014 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
145432000 USD
CY2012 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
121000 USD
CY2013 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
16000 USD
CY2014 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
61000 USD
CY2012 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 USD
CY2013 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
13000000 USD
CY2014 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
12564000 USD
CY2013Q2 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
26523 shares
CY2013Q2 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
620122 shares
CY2014Q3 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
348535 shares
CY2013Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
30099000 USD
CY2014Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
32256000 USD
CY2013Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
1414000 USD
CY2014Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
4974000 USD
CY2012 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
91000 USD
CY2013 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
84000 USD
CY2014 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
81000 USD
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
900000 USD
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1554000 USD
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
177096000 USD
CY2014Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
183120000 USD
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
154872000 USD
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
161888000 USD
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
461700000 USD
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
500600000 USD
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
217500000 USD
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
246700000 USD
CY2013Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
6357000 USD
CY2014Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
9777000 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
9841000 USD
CY2014Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
6968000 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
2679000 USD
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
2174000 USD
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
158323000 USD
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
165020000 USD
CY2013Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
223000 USD
CY2014Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
304000 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Deferred Expense Deferred Financing Costs
DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts
11214000 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Deferred Expense Deferred Financing Costs
DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts
11947000 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
223000 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
304000 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
6734000 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
5218000 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
515000 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
0 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
310000 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
935000 USD
CY2012 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1000000 USD
CY2013 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1000000 USD
CY2014 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1200000 USD
CY2012 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.06
CY2013 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.06
CY2014 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.06
CY2012 us-gaap Defined Contribution Plan Employers Matching Contribution Annual Vesting Percentage
DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage
0.25
CY2013 us-gaap Defined Contribution Plan Employers Matching Contribution Annual Vesting Percentage
DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage
0.25
CY2014 us-gaap Defined Contribution Plan Employers Matching Contribution Annual Vesting Percentage
DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage
0.25
CY2014 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
1.00
CY2012 us-gaap Depreciation
Depreciation
5000000 USD
CY2013 us-gaap Depreciation
Depreciation
6900000 USD
CY2014 us-gaap Depreciation
Depreciation
8200000 USD
CY2012 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11030000 USD
CY2013 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11806000 USD
CY2014 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12223000 USD
CY2012 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.08
CY2013Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.20
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.20
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.39
CY2013Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.83
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.53
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.19
CY2014Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.93
CY2012 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0040
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0022
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0028
CY2012 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.3400
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.3400
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.3400
CY2012 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.3234
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.2932
CY2014 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.3879
CY2012 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.0137
CY2013 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.0549
CY2013 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.38
CY2013 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0056
CY2014 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.0071
CY2012 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.0001
CY2013 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.0018
CY2014 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.0150
CY2012 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0118
CY2013 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0421
CY2014 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.0404
CY2012 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.0050
CY2013 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.0498
CY2014 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.0126
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6887000 USD
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10243000 USD
CY2014Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
29900000 USD
CY2013 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0
CY2013 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P2Y5M15D
CY2014Q2 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
1400000 USD
CY2014 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
1400000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
14860000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
18836000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
2656000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
3251000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1496000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1806000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2190000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2665000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
32900000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
32900000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
18040000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
14064000 USD
CY2014 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
32900000 USD
CY2012 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2013 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-325000 USD
CY2014 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-23203000 USD
CY2012 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
51240000 USD
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
64077000 USD
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
66841000 USD
CY2013Q4 us-gaap Goodwill
Goodwill
37536000 USD
CY2014Q4 us-gaap Goodwill
Goodwill
37536000 USD
CY2013 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2014 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2012 us-gaap Gross Profit
GrossProfit
92336000 USD
CY2013Q1 us-gaap Gross Profit
GrossProfit
25155000 USD
CY2013Q2 us-gaap Gross Profit
GrossProfit
26833000 USD
CY2013Q3 us-gaap Gross Profit
GrossProfit
27395000 USD
CY2013Q4 us-gaap Gross Profit
GrossProfit
33018000 USD
CY2013 us-gaap Gross Profit
GrossProfit
112401000 USD
CY2014Q1 us-gaap Gross Profit
GrossProfit
32808000 USD
CY2014Q2 us-gaap Gross Profit
GrossProfit
35765000 USD
CY2014Q3 us-gaap Gross Profit
GrossProfit
38042000 USD
CY2014Q4 us-gaap Gross Profit
GrossProfit
36673000 USD
CY2014 us-gaap Gross Profit
GrossProfit
143288000 USD
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-51655000 USD
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-44874000 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-51358000 USD
CY2012 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
212000 USD
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
100000 USD
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
142000 USD
CY2012 us-gaap Income Taxes Paid
IncomeTaxesPaid
11000 USD
CY2013 us-gaap Income Taxes Paid
IncomeTaxesPaid
321000 USD
CY2014 us-gaap Income Taxes Paid
IncomeTaxesPaid
124000 USD
CY2012 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
13513000 USD
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4514000 USD
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
10069000 USD
CY2012 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2863000 USD
CY2013 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-4545000 USD
CY2014 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
654000 USD
CY2012 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3029000 USD
CY2013 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-5403000 USD
CY2014 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3635000 USD
CY2012 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-185000 USD
CY2013 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
76000 USD
CY2014 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
831000 USD
CY2012 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
898000 USD
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
320000 USD
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-662000 USD
CY2012 us-gaap Interest And Debt Expense
InterestAndDebtExpense
15794000 USD
CY2013 us-gaap Interest And Debt Expense
InterestAndDebtExpense
16889000 USD
CY2014 us-gaap Interest And Debt Expense
InterestAndDebtExpense
14687000 USD
CY2012 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
600000 USD
CY2013 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
300000 USD
CY2014 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
200000 USD
CY2012 us-gaap Interest Expense Debt
InterestExpenseDebt
16409000 USD
CY2013 us-gaap Interest Expense Debt
InterestExpenseDebt
17111000 USD
CY2014 us-gaap Interest Expense Debt
InterestExpenseDebt
36762000 USD
CY2012 us-gaap Interest Paid
InterestPaid
6197000 USD
CY2013 us-gaap Interest Paid
InterestPaid
5704000 USD
CY2014 us-gaap Interest Paid
InterestPaid
4567000 USD
CY2013Q4 us-gaap Interest Payable Current
InterestPayableCurrent
225000 USD
CY2014Q4 us-gaap Interest Payable Current
InterestPayableCurrent
168000 USD
CY2013Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
7394000 USD
CY2014Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
11992000 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
9464000 USD
CY2014Q4 us-gaap Liabilities
Liabilities
218327000 USD
CY2014 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1500000 USD
CY2012 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1700000 USD
CY2013 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1600000 USD
CY2014Q4 us-gaap Inventory Net
InventoryNet
13099000 USD
CY2013Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
399000 USD
CY2014Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
853000 USD
CY2013Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1671000 USD
CY2014Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
254000 USD
CY2012 us-gaap Investment Income Interest
InvestmentIncomeInterest
110000 USD
CY2013 us-gaap Investment Income Interest
InvestmentIncomeInterest
124000 USD
CY2014 us-gaap Investment Income Interest
InvestmentIncomeInterest
129000 USD
CY2013Q4 us-gaap Liabilities
Liabilities
163358000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
287955000 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
302156000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
42374000 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
44296000 USD
CY2013Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
113651000 USD
CY2014Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
168994000 USD
CY2012 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3388000 USD
CY2013 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
96393000 USD
CY2014 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4032000 USD
CY2012 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10991000 USD
CY2013 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7307000 USD
CY2014 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11486000 USD
CY2012 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-29059000 USD
CY2013 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3348000 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8920000 USD
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-51867000 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-10665000 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-10519000 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-21290000 USD
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
-2500000 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-44974000 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-6144000 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-29111000 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-10845000 USD
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
-5400000 USD
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-51500000 USD
CY2012 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-15684000 USD
CY2013 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-15739000 USD
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-39061000 USD
CY2014 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Customer
CY2012 us-gaap Operating Expenses
OperatingExpenses
128307000 USD
CY2013 us-gaap Operating Expenses
OperatingExpenses
141536000 USD
CY2014 us-gaap Operating Expenses
OperatingExpenses
155585000 USD
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
-35971000 USD
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-29135000 USD
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-12297000 USD
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
17257000 USD
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
2226000 USD
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
2181000 USD
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
2290000 USD
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
2284000 USD
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
2196000 USD
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
6080000 USD
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2261000 USD
CY2013 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1351000 USD
CY2012 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2473000 USD
CY2013Q4 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
1351000 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1825000 USD
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5291000 USD
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1943000 USD
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2774000 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5940000 USD
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1300000 USD
CY2012 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1539000 USD
CY2013 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3265000 USD
CY2014 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
8665000 USD
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10991000 USD
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7307000 USD
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11486000 USD
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4022000 USD
CY2012 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
0 USD
CY2013 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
0 USD
CY2014 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
194490000 USD
CY2012 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4927000 USD
CY2013 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
102652000 USD
CY2014 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
11586000 USD
CY2012Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1992000 USD
CY2013Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
3090000 USD
CY2014Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
2614000 USD
CY2013Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
1173000 USD
CY2014Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
981000 USD
CY2013Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
1917000 USD
CY2014Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
1633000 USD
CY2013 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
2967000 USD
CY2014 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
2141000 USD
CY2013 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
4065000 USD
CY2014 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
1665000 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
66818000 USD
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
59985000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
32356000 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
37069000 USD
CY2012 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3409000 USD
CY2013 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4741000 USD
CY2014 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3254000 USD
CY2012 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
0 USD
CY2013 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
994000 USD
CY2014 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
3858000 USD
CY2012 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
CY2013 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2000000 USD
CY2014 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
189521000 USD
CY2012 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
24359000 USD
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21765000 USD
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
27900000 USD
CY2013Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
100000 USD
CY2014Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1200000 USD
CY2012 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-1538000 USD
CY2013 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-3265000 USD
CY2014 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-8665000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-526525000 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-578025000 USD
CY2012 us-gaap Sales Revenue Net
SalesRevenueNet
211369000 USD
CY2013Q1 us-gaap Sales Revenue Net
SalesRevenueNet
57356000 USD
CY2013Q2 us-gaap Sales Revenue Net
SalesRevenueNet
60092000 USD
CY2013Q3 us-gaap Sales Revenue Net
SalesRevenueNet
61103000 USD
CY2013Q4 us-gaap Sales Revenue Net
SalesRevenueNet
68533000 USD
CY2013 us-gaap Sales Revenue Net
SalesRevenueNet
247084000 USD
CY2014Q1 us-gaap Sales Revenue Net
SalesRevenueNet
69161000 USD
CY2014Q2 us-gaap Sales Revenue Net
SalesRevenueNet
72013000 USD
CY2014Q3 us-gaap Sales Revenue Net
SalesRevenueNet
74985000 USD
CY2014Q4 us-gaap Sales Revenue Net
SalesRevenueNet
72561000 USD
CY2014 us-gaap Sales Revenue Net
SalesRevenueNet
288720000 USD
CY2012 us-gaap Segment Reporting Disclosure Of Major Customers
SegmentReportingDisclosureOfMajorCustomers
1
CY2013 us-gaap Segment Reporting Disclosure Of Major Customers
SegmentReportingDisclosureOfMajorCustomers
1
CY2014 us-gaap Segment Reporting Disclosure Of Major Customers
SegmentReportingDisclosureOfMajorCustomers
2
CY2012 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
52708000 USD
CY2013 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
55694000 USD
CY2014 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
60844000 USD
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
9920000 USD
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
12683000 USD
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
22519000 USD
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
5200000 USD
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
927900 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
19.59
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
9000000 USD
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
17800000 USD
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
20418000 USD
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
65268 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
838846 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
12.04
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
15.42
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
15.88
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
35361000 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1828613 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1847669 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.46
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
26.99
CY2012 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
392000 USD
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y5M0D
CY2014 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
754522 shares
CY2014Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
12600000 USD
CY2013 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
13326000 USD
CY2014 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
12564000 USD
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
34437000 USD
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1754359 shares
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
14.69
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
28.22
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
38.97
CY2013Q4 us-gaap Share Price
SharePrice
37.10
CY2014Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
24597000 USD
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y9M0D
CY2013 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
445000 USD
CY2014 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
583000 USD
CY2013Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
97800000 USD
CY2013 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
92812000 USD
CY2012 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4592000 USD
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
9461000 USD
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
11091000 USD
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
82735000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
44176000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
124597000 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
83829000 USD
CY2013Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
3928000 USD
CY2014Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
3843000 USD
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2014 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
6700000 USD
CY2012 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
47924324 shares
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
54010887 shares
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
55628542 shares
CY2014 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Credit Risk</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that subject the Company to credit risk primarily consist of cash and cash equivalents. The Company maintains the majority of its cash with </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">two</font><font style="font-family:inherit;font-size:10pt;"> accredited financial institutions.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company purchases complete OmniPods from Flextronics International Ltd., its single source supplier. As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2013</font><font style="font-family:inherit;font-size:10pt;">, liabilities from this vendor represented approximately </font><font style="font-family:inherit;font-size:10pt;">24%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">36%</font><font style="font-family:inherit;font-size:10pt;"> of the combined balance of accounts payable, accrued expenses and other current liabilities, respectively.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2014</font><font style="font-family:inherit;font-size:10pt;"> revenue from </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> customers represented </font><font style="font-family:inherit;font-size:10pt;">15%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">11%</font><font style="font-family:inherit;font-size:10pt;"> of total revenue, respectively. In the years ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2013</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2012</font><font style="font-family:inherit;font-size:10pt;">, revenue from </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> customer represented </font><font style="font-family:inherit;font-size:10pt;">13%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">11%</font><font style="font-family:inherit;font-size:10pt;"> of total revenue, respectively. </font></div></div>
CY2014 us-gaap Nature Of Operations
NatureOfOperations
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nature of the Business</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is primarily engaged in the development, manufacturing and sale of its proprietary OmniPod Insulin Management System (the &#8220;OmniPod System&#8221;), an innovative, discreet and easy-to-use insulin infusion system for people with insulin-dependent diabetes. The OmniPod System features a unique disposable tubeless OmniPod which is worn on the body for approximately three days at a time and the handheld, wireless Personal Diabetes Manager (&#8220;PDM&#8221;). Conventional insulin pumps require people with insulin-dependent diabetes to learn to use, manage and wear a number of cumbersome components, including up to </font><font style="font-family:inherit;font-size:10pt;">42</font><font style="font-family:inherit;font-size:10pt;">&#160;inches of tubing. In contrast, the OmniPod System features two discreet, easy-to-use devices that eliminate the need for a bulky pump, tubing and separate blood glucose meter, provides for virtually pain-free automated cannula insertion, communicates wirelessly and integrates a blood glucose meter. </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2011, the Company acquired Neighborhood Holdings, Inc. and its wholly-owned subsidiaries (collectively, &#8220;Neighborhood Diabetes&#8221;) in order to expand the Company&#8217;s full suite diabetes management product offerings and obtain access to a larger number of insulin dependent patients. Through Neighborhood Diabetes, the Company is able to provide customers with blood glucose testing supplies, traditional insulin pumps, pump supplies and pharmaceuticals and has the ability to process claims as either durable medical equipment or through pharmacy benefits.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company began commercial sale of the OmniPod System in the United States in 2005. The Company sells the OmniPod System and other diabetes management supplies in the United States through direct sales to customers or through it's distribution partners. The OmniPod System is currently available in multiple countries in Europe through it's exclusive partnerships with Ypsomed Distribution AG (&#8220;Ypsomed&#8221;) and in Canada. The Company has been selling its new OmniPod System since 2013. The new OmniPod System is approximately one-third smaller and one-quarter lighter than the original model, while maintaining the same features and operating capabilities. By December 31, 2013, all customers have been transitioned to the new OmniPod System.</font></div></div>
CY2014 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates in Preparation of Financial Statements</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expense during the reporting periods. The most significant estimates used in these financial statements include the valuation of stock-based compensation expense, accounts receivable, inventories, goodwill, deferred revenue, and equity instruments, the lives of property and equipment and intangible assets, as well as warranty and doubtful accounts allowance reserve calculations. Actual results may differ from those estimates.</font></div></div>

Files In Submission

Name View Source Status
0001145197-15-000020-index-headers.html Edgar Link pending
0001145197-15-000020-index.html Edgar Link pending
0001145197-15-000020.txt Edgar Link pending
0001145197-15-000020-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
podd-20141231.xml Edgar Link completed
podd-20141231.xsd Edgar Link pending
podd-20141231_cal.xml Edgar Link unprocessable
podd-20141231_def.xml Edgar Link unprocessable
podd-20141231_lab.xml Edgar Link unprocessable
podd-20141231_pre.xml Edgar Link unprocessable
podd20131231charta01.jpg Edgar Link pending
poddex1049_2014123110k.htm Edgar Link pending
poddex1050_2014123110k.htm Edgar Link pending
poddex1051_2014311210k.htm Edgar Link pending
poddex1052_2014123110k.htm Edgar Link pending
poddex1053_2014123110k.htm Edgar Link pending
poddex1054_2014123110k.htm Edgar Link pending
poddex1055_2014123110k.htm Edgar Link pending
poddex1056_2014123110k.htm Edgar Link pending
poddex211_2014123110k.htm Edgar Link pending
poddex231_2014123110k.htm Edgar Link pending
poddex311_2014123110k.htm Edgar Link pending
poddex312_2014123110k.htm Edgar Link pending
poddex321_2014123110k.htm Edgar Link pending
podd_2014123110k.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending